Citas bibligráficas
Pantoja, M., (2013). Niveles de Apolipoproteina-B sericos, como indicador de riesgo coronario en individuos de altura y del nivel del mar [Tesis, Universidad Nacional Mayor de San Marcos]. https://hdl.handle.net/20.500.12672/3440
Pantoja, M., Niveles de Apolipoproteina-B sericos, como indicador de riesgo coronario en individuos de altura y del nivel del mar [Tesis]. PE: Universidad Nacional Mayor de San Marcos; 2013. https://hdl.handle.net/20.500.12672/3440
@misc{renati/482276,
title = "Niveles de Apolipoproteina-B sericos, como indicador de riesgo coronario en individuos de altura y del nivel del mar",
author = "Pantoja Napa, Miguel Angel",
publisher = "Universidad Nacional Mayor de San Marcos",
year = "2013"
}
--- The present study determined the concentrations of apolipoprotein-B as an indicator of coronary risk in rural populations of the height of Cerro de Pasco to 4340 msnm and urban populations of the level of the sea of Lima at 25 meters. The quantification of this structural protein of atherogenic lipoproteins, and its concentration, is a reflection of the number of particles present atherogenic. Serum concentrations of apolipoprotein-B (Apo-B) were studied in 51 subjects aged between 22 and 48 years of Cerro de Pasco; and of 48 subjects aged between 23 and 50 years of Lima. Se they were measured by enzymatic Test for Total cholesterol, triglycerides, HDL-cholesterol, LDL cholesterol; and Test Inmunoturbidimétrico to Apo-B. The found values of Apo-B ±DS for the town of Cerro de Pasco was 109. 39±25. 18 mg % and for the population of Lima was 106. 3±33. 12 mg %, which indicates a rise in the levels of this apolipoprotein, which was not expected in this population, and reflecting the change of habits dietary, especially in the intake of carbohydrates and lipids. The correlation between the Apo-B and LDL-cholesterol was 0.9196 for the population of Cerro de Pasco and 0.8932 for the population of Lima, which tells us that both parameters are closely linked in terms of quantity and hence in terms of consequences for the evaluated cardiovascular risk. Key words: Lipoprotein, apolipoprotein-B (Apo-B), coronary risk and atherosclerosis.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons